Aspen Aerogels FY2025 EPS Estimate Cut by Seaport Res Ptn

Aspen Aerogels, Inc. (NYSE:ASPN) – Research analysts at Seaport Res Ptn dropped their FY2025 earnings per share (EPS) estimates for shares of Aspen Aerogels in a research note issued to investors on Sunday, November 16th. Seaport Res Ptn analyst T. Curran now expects that the construction company will post earnings per share of ($0.35) for the year, down from their prior forecast of ($0.06). The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.17 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q4 2025 earnings at ($0.19) EPS, Q1 2026 earnings at ($0.18) EPS, Q2 2026 earnings at ($0.14) EPS, Q3 2026 earnings at ($0.04) EPS, FY2026 earnings at ($0.34) EPS and FY2027 earnings at $0.22 EPS.

A number of other equities analysts also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Aspen Aerogels in a research note on Wednesday, October 8th. Zacks Research cut shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Barclays reduced their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a report on Friday, November 7th. Finally, Canaccord Genuity Group lowered their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $12.67.

Aspen Aerogels Stock Up 2.8%

Shares of NYSE ASPN opened at $3.15 on Wednesday. Aspen Aerogels has a 12-month low of $2.98 and a 12-month high of $15.38. The firm’s 50-day simple moving average is $6.83 and its 200 day simple moving average is $6.67. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The company has a market cap of $259.92 million, a price-to-earnings ratio of -0.83 and a beta of 2.85.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The business had revenue of $73.02 million for the quarter, compared to the consensus estimate of $73.42 million. During the same quarter in the previous year, the company posted ($0.17) EPS. Aspen Aerogels’s revenue for the quarter was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. lifted its position in Aspen Aerogels by 6.8% during the 2nd quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after buying an additional 1,687 shares in the last quarter. Legal & General Group Plc increased its position in shares of Aspen Aerogels by 3.6% in the second quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock valued at $397,000 after acquiring an additional 2,324 shares during the last quarter. Osaic Holdings Inc. raised its holdings in Aspen Aerogels by 29.1% during the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after acquiring an additional 2,390 shares in the last quarter. SBI Securities Co. Ltd. boosted its position in Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after purchasing an additional 2,551 shares during the last quarter. Finally, Journey Strategic Wealth LLC grew its stake in Aspen Aerogels by 17.3% in the first quarter. Journey Strategic Wealth LLC now owns 17,596 shares of the construction company’s stock valued at $112,000 after purchasing an additional 2,596 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total value of $183,609.35. Following the transaction, the chief executive officer owned 494,011 shares of the company’s stock, valued at $1,595,655.53. This represents a 10.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.